Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced a significant milestone for its flagship Oncotype DX Breast Recurrence Score® test: ...

Exact Sciences' Oncotype DX Breast Recurrence Score test has now been used by more than 2,000,000 patients worldwide. The test is widely used to guide individualized breast cancer treatment and help ...

Onco-Innovations highlights three key aspects of the studies: the nanoparticle formulation of the PNKP compound's ability to target cancer site; the effectiveness of this formulation as a standalone ...

An AI risk tool predicted death, bleeding, and ischaemic events after heart attack in patients with cancer, supporting ...

Renova Hospitals launches RIOS – Renova Institute of Onco Sciences to deliver coordinated, patient-centered multidisciplinary cancer care ...

VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce, further to its ...

VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Onco-Innovations Limited (ONCO:CA)(Frankfurt:W1H)(WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company")is pleased ...

The investigators reported the results of a prospective, randomized, phase 3 trial studying the best individual therapy for women who have node-negative, estrogen-receptor‒positive (ER-positive) ...

By: Dr. Amrit Kaur Kaler For patients diagnosed with blood cancers such as leukemia, lymphoma, and multiple myeloma, the ...

Children should be trained and explained about cancer symptoms in schools so that they can focus on spotting them within ...

ACS, the first AI-driven model tailored to cancer patients who suffer heart attacks. By combining cancer-specific and ...

Cancer patients who suffer a heart attack face a dangerous mix of risks, which makes their clinical treatment particularly challenging. As a result, patients with cancer have been systematically ...